A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

Abstract Introduction Historically, patients with skin of color are underdiagnosed with psoriasis and underrepresented in clinical trials. In this study, we assess the efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis by race and ethnicity in the open label ext...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Adis, Springer Healthcare 2024-10-01
Serie:	Dermatology and Therapy
Soggetti:	Skin of color Psoriasis Race Ethnicity Efficacy Diversity
Accesso online:	https://doi.org/10.1007/s13555-024-01268-z
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!